Germa Caroline 4
4 · Ikena Oncology, Inc. · Filed Mar 5, 2024
Insider Transaction Report
Form 4
Germa Caroline
Chief Medical Officer
Transactions
- Award
Stock Option (Right to Buy)
2024-03-01+579,100→ 579,100 totalExercise: $1.47Exp: 2034-03-01→ Common Stock (579,100 underlying)
Footnotes (1)
- [F1]12.5% of the shares subject to this option shall vest and become exercisable on September 1, 2024, with the remainder vesting in forty-two (42) equal monthly installments thereafter.